original ) (raw )Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy
Saed Mirzadeh
Cancer research, 1993
View PDFchevron_right
Direct Procedure for the Production of 211At-Labeled Antibodies with an -Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate
Sofia H L Frost , Tom Bäck
Journal of Nuclear Medicine, 2008
View PDFchevron_right
Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy
Robert Kozak
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Streptavidin in Antibody Pretargeting. 5. Chemical Modification of Recombinant Streptavidin for Labeling with the α-Particle-Emitting Radionuclides 213 Bi and 211 At
D Scott Wilbur
Bioconjugate Chemistry, 2008
View PDFchevron_right
Preparation and evaluation of 211At labelled antineoplastic antibodies
Siva sankar reddy Sriyapureddy
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, 2007
View PDFchevron_right
Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
Fred Verzijlbergen
2017
View PDFchevron_right
Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies
Ronnie Mease
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
View PDFchevron_right
Preparation of TH 227 -Labeled Radioimmunoconjugates, Assessment of Serum Stability and Antigen Binding Ability
Jostein Dahle
Cancer Biotherapy and Radiopharmaceuticals, 2007
View PDFchevron_right
Shelf-Life of ɛ-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugates, Precursors for (211)At Labeling of Antibodies
Emma Aneheim , Stellan Holgersson
Cancer biotherapy & radiopharmaceuticals, 2015
View PDFchevron_right
Technetium-labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC (CPITC=carboxyphenylisothiocyanate) labeling of B72.3 and NP4 whole antibodies and NP4 F(ab')2
david Nowotnik
Bioconjugate Chemistry, 1991
View PDFchevron_right
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis
Gamal Akabani
International Journal of Radiation Oncology Biology Physics, 1999
View PDFchevron_right
Preparation of 105Rh Labeled Monoclonal Antibody (MAb B72.3) Using Aminobenzylpropyleneamineoxime as the Bifunctional Chelating Agent; Comparison to 131I Labeled MAb B72.3
Alan Ketring
Radiochimica Acta, 1999
View PDFchevron_right
An improved synthesis of S-benzoyl mercaptoacetyltriglycine as BFCA and the labeling of IgG with carrier-free 188 Re
LI JUNLING
Journal of Radioanalytical and Nuclear Chemistry, 2003
View PDFchevron_right
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer
Maarten Brom
EJNMMI research, 2012
View PDFchevron_right
The labeling of high affinity sites of antibodies with 99mTc
Susan Heald
International Journal of Nuclear Medicine and Biology, 1985
View PDFchevron_right
Reassessment of Diethylenetriaminepentaacetic Acid (DTPA) as a Chelating Agent for Indium-111 Labeling of Polypeptides Using a Newly Synthesized Monoreactive DTPA Derivative
Yasushi Arano
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Labeling of monoclonal antibodies with radionuclides
Seetharama Acharya
Seminars in Nuclear Medicine, 1989
View PDFchevron_right
Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide
Ula Karczmarczyk
Nuclear medicine and biology, 2010
View PDFchevron_right
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry
Robert Kozak
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999
View PDFchevron_right
Direct labeling of monoclonal antibodies with 99mTc and radioimmunodetection of a murine mammary carcinoma with 99mTc-B2C114
Alberto Horenstein
Journal of nuclear biology and medicine (Turin, Italy: 1991)
View PDFchevron_right
Investigations of ascorbate for direct labeling of antibodies with technetium-99m
Miklos Fogarasi
PubMed, 1994
View PDFchevron_right
Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent
David Kukis
Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 1990
View PDFchevron_right
New Bifunctional Chelators for 225Ac and 227Th Radioimmunotherapy
D. Wilbur
Journal of Medical Imaging and Radiation Sciences, 2019
View PDFchevron_right
Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site
Akira Odani
Annals of Nuclear Medicine, 2009
View PDFchevron_right
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent
D Scott Wilbur
Proceedings of the National Academy of Sciences, 1988
View PDFchevron_right
Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111
Mercedes Ebbert
1985
View PDFchevron_right
Investigation of trivalent 201TI as a possible radionuclide for labelling of MoAbs
Alexandra Varvarigou
Journal of Labelled Compounds and Radiopharmaceuticals, 2001
View PDFchevron_right
Labeling of human IgG with rhodium-105 using a new pentadentate bifunctional ligand. 7/23/
Pillai M.R.A.
View PDFchevron_right
Rhenium-186-mercaptoacetyltriglycine-labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor-bearing Nude Mice
Takatoshi Michigishi
Cancer Science, 1998
View PDFchevron_right